| 达格列净二甲双胍缓释片(Ⅰ) | AstraZeneca AB | 达格列净5mg(以C₂₁H₂₅ClO₆计)和盐酸二甲双胍500mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20230077 | 2023-12-18 | 查看 |
| 达格列净二甲双胍缓释片(Ⅲ) | AstraZeneca AB | 达格列净5mg(以C₂₁H₂₅ClO₆计)和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20230078 | 2023-06-21 | 查看 |
| 达格列净二甲双胍缓释片(Ⅱ) | AstraZeneca AB | 达格列净2.5 mg(以C₂₁H₂₅ClO₆计)和盐酸二甲双胍1000 mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20230076 | 2023-06-21 | 查看 |
| 达格列净二甲双胍缓释片(Ⅳ) | AstraZeneca AB | 达格列净10mg(以C₂₁H₂₅ClO₆计)和盐酸二甲双胍500mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20230079 | 2023-06-21 | 查看 |
| 达格列净二甲双胍缓释片(Ⅰ) | AstraZeneca AB | 达格列净10mg(以C₂₁H₂₅ClO₆计)和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20230080 | 2023-06-21 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅱ) | AstraZeneca AB | 每片含沙格列汀5mg和盐酸二甲双胍500mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170254 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅱ) | AstraZeneca AB | 每片含沙格列汀5mg和盐酸二甲双胍500mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170253 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅱ) | AstraZeneca AB | 每片含沙格列汀5mg和盐酸二甲双胍500mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20171050 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅰ) | AstraZeneca AB | 每片含沙格列汀5mg和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170252 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅰ) | AstraZeneca AB | 每片含沙格列汀5mg和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170251 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅰ) | AstraZeneca AB | 每片含沙格列汀5mg和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20171049 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅲ) | AstraZeneca AB | 每片含沙格列汀2.5mg和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170256 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅲ) | AstraZeneca AB | 每片含沙格列汀2.5mg和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170255 | 2021-10-26 | 查看 |
| 沙格列汀二甲双胍缓释片(Ⅲ) | AstraZeneca AB | 每片含沙格列汀2.5mg和盐酸二甲双胍1000mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20171051 | 2021-10-26 | 查看 |
| 达格列净片 | AstraZeneca AB | 5mg(以C21H25ClO6计) | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170205 | 2021-09-02 | 查看 |
| 达格列净片 | AstraZeneca AB | 5mg(以C21H25ClO6计) | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170118 | 2021-09-02 | 查看 |
| 达格列净片 | AstraZeneca AB | 5mg (以C21H25ClO6计) | AstraZeneca Pharmaceuticals LP | 国药准字HJ20170117 | 2021-09-02 | 查看 |
| 沙格列汀片 | AstraZeneca AB | 5mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20160090 | 2025-04-02 | 查看 |
| 沙格列汀片 | AstraZeneca AB | 5mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20160089 | 2025-04-02 | 查看 |
| 沙格列汀片 | AstraZeneca AB | 5mg | AstraZeneca Pharmaceuticals LP | 国药准字HJ20160085 | 2025-04-02 | 查看 |
